Occurrences of endocrine disrupting compounds and pharmaceuticals in the aquatic environment and their removal from drinking water: Challenges in the context of the developing world

Desalination

Volumn 248, Issue 1-3, 2009, Pages 578-585

  Rahman, M F ^a   Yanful, E K ^a   Jasim, S Y ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Walkerton Clean Water Centre   (Canada)

Author keywords

Advanced water treatment technologies; EDCs; Environmental health; PPCPs

Indexed keywords

ADVANCED TREATMENT; ADVANCED WATER TREATMENT TECHNOLOGIES; APPROPRIATE TECHNOLOGIES; AQUATIC ENVIRONMENTS; DEVELOPING WORLD; DRINKING WATER; DRINKING WATER TREATMENT; EDCS; ENDOCRINE DISRUPTING COMPOUND; ENVIRONMENTAL HEALTH; OZONATION; PERCEIVED RISK; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; PPCPS;

CHEMICALS; CHEMICALS REMOVAL (WATER TREATMENT); DEVELOPING COUNTRIES; DEWATERING; ENVIRONMENTAL ENGINEERING; HAZARDOUS MATERIALS; HEALTH; HEALTH RISKS; LAWS AND LEGISLATION; OZONE; OZONE WATER TREATMENT; OZONIZATION; POTABLE WATER; TECHNOLOGY; WATER SUPPLY;

WATER RECYCLING;

ADVANCED TECHNOLOGY; AQUATIC ENVIRONMENT; DEVELOPING WORLD; DRINKING WATER; DRUG; ENDOCRINE DISRUPTOR; POLLUTANT REMOVAL; WATER TREATMENT;

EID: 70349506146     PISSN: 00119164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.desal.2008.05.105     Document Type: Article

References (44)

1. Ongley E.D. Matching water quality programs to management needs in developing countries: the challenge of program modernization. Proceedings of the Monitoring Tailor Made - II. Why to Integrate Water Quality Information, Nunspeet, Netharlands (1996) 13-20
2. Birklett J.W., and Lester J.N. Scope of the problem. In: Birklett J.W., and Lester J.N. (Eds). Endocrine Disruptors in Wastewater and Sludge Treatment Processes (2003), Lewis Publishers, New York 1-34
3. USEPA, Removal of Endocrine Disruptor Chemicals using Drinking Water Treatment Processes, EPA/625/R-00/015, 2001.
4. Snyder S.A., Adham S., Redding A.M., Cannon F.S., Decarolis J., Oppenheimer J., Wert E.C., and Yoon Y. Role of membranes and activated carbon removal of endocrine disruptors and pharmaceuticals. Desalination 202 (2006) 156-181
5. Kim S.D., Cho J., Kim I.S., Vanderford B.J., and Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters. Water Res. 41 (2007) 1013-1021
6. Lintelmann J., Katayama A., Kurihara N., Shore L., and Wenzel A. Endocrine disruptors in the environment. Pure Appl. Chem. 75 5 (2003) 631-681
7. Jasim S.Y., Irabelli A., Yang P., Ahmed S., and Schweitzer L. Presence of pharmaceuticals and pesticides in Detroit river water and the effect of ozone on removal. Ozone: Sci. Eng. 28 (2006) 415-423
8. Fry D.M. Reproductive effects in birds exposed to pesticides and industrial chemicals. Environ. Health Perspect. 103 7 (1995) 165-171
9. Safe S.H. Endocrine disruption and human health-is there a problem? An update. Environ. Health Perspect. 108 6 (2000) 487-493
10. Ejaj S., Akram W., Lim C.W., Lee J.J., and Hussain I. Endocrine disrupting pesticides: a leading cause of cancer among rural people in Pakistan. Exp. Oncol. 26 2 (2004) 98-105
11. Pocar P., Bervini T.A.L., Fischer B., and Gandolfi F. The impact of endocrine disruptors on oocyte competence. Reproduction 125 (2003) 313-325
12. Mackenzie C.A., Lockridge A., and Keith M. Declining sex ratio in a first nation community. Environ. Health Perspect. 113 10 (2005) 1295-1298
13. Inadera H. The immune system as a target for environmental chemicals: xenoestrogen and other compounds. Toxicol. Lett. 164 (2006) 191-206
14. Ahmed S.A. The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology 150 (2000) 191-206
15. Birnbaum L.S. Endocrine effects of prenatal exposure to PCBs, dioxins and other xenobiotics: implications for policy and future research. Environ. Health Perspect. 102 8 (1994) 676-679
16. Voldner E.C., and Li Y.F. Global usage of selected persistent organochlorines. Sci. Total Environ. 160/161 (1995) 201-210
17. Fick J., Lindberg R.H., Tysklind M., Haemig P.D., Waledenstrom J., Wallensten A., and Olsen B. Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for the development of resistance by influenza A virus. PloS ONE 2 10 (2007) 1-5 e986
18. Okeke I.N., Lamikanra A., and Edelman R. Socio-economic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg. Infect. Dis. 5 1 (1999) 18-26
19. Webb S., Ternes T., Gilbert M., and Olejniczak K. Indirect human exposure to pharmaceuticals via drinking water. Toxicol. Lett. 142 3 (2003) 157-167
20. Purdom C.E., Hardiman P.A., Bye V.J., Eno N.C., Tyler C.R., and Sumpter J.P. Estrogenic effects of effluents from sewage treatment works. Chem. Ecol. 8 (1994) 275-285
21. Gomes R., and Lester J.N. Endocrine disrupters in drinking water and water reuse. In: Birklett J.W., and Lester J.N. (Eds). Endocrine Disruptors in Wastewater and Sludge Treatment Processes (2003), Lewis Publishers, New York 219-266
22. http://www.theglobeandmail.com/servlet/story/RTGAM.20080119.wbisphenol19/BNStory/National/home [accessed 1045 hrs, 2007 23 January].
23. Fahnrich K.A., Pravda M., and Guilbault G.G. Immunological detection of polycyclic aromatic hydrocarbond (PAHs). Anal. Lett. 35 8 (2002) 1269-1300
24. Maier M., Maier D., and Lloyd B.J. Factors influencing the mobilization of polycyclic aromatic hydrocarbons (PAHs) from the coal-tar Lining of Water Mains. Water Res. 34 (2000) 773
25. Westerhoff P. Removal of endocrine disruptors, pharmaceuticals and personal care products during water treatment. Southwest Hydrol. 2 6 (2003) 18-19
26. D. Khiari, Endocrine disruptors, pharmaceuticals and personal care products in drinking water: an overview of AwwaRF research to date, Drinking Water Research, January/February 2007 [accessed 1600 hrs, 2008 30 January]; http://www.cwwa.ca/pdf_files/AwwaRF_EDC%20article1.pdf.
27. Snyder S.A., Westerhoff P., Yoon Y., and Sedlak D.L. Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ. Eng. Sci. 20 5 (2003) 449-469
28. Jones O.A.H., Lester J.N., and Voulvoulis N. Pharmaceuticals: a threat to drinking water?. Trends Biotechnol. 23 4 (2005) 163-167
29. Ternes T.A., Meisenheimer M., Mcdowell D., Sacher F., Brauch H.-J., Preuss G., Wilme U., and Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36 (2002) 3855-3863
30. Von Gunten U. Ozonation of drinking water: Part I. Oxidation kinetics and product formation. Water Res. 37 (2003) 1443-1467
31. Huber M.M., Canonica S., Park G.-Y., and Von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37 (2003) 1016-1024
32. Vineis P. A case in point: occupational cancer. Bull. World Health Org. 78 9 (2000) 1158-1159
33. Jamall I.S., and Davis B. Chemicals and environmentally caused diseases in developing countries. Infect. Dis. Clin. N. Am. 5 2 (1991) 365-373
34. Minh N.H., Minh T.B., Kajiwara N., Subramanian A., Iwata H., Tana T.S., Baburajendran R., Karuppiah S., Viet P.H., Tuyen B.C., and Tanabe S. Contamination of persistent organic pollutants in dumping sites of Asian developing countries: implication of emerging pollutant sources. Arch. Environ. Contaminat. Toxicol. 50 (2006) 474-481
35. Kunisue T., Someya M., Kayama F., Jin Y., and Tanabe S. Persistent organic pollutants in human breast milk collected from Dalian and Shenyang, China. Org. Compd. 66 (2004) 2779-2784
36. Wong M.H., Leung A.O.W., Chan J.K.Y., and Choi M.P.K. A review of the usage of POP pesticides in China, with emphasis on DDT loadings in human milk. Chemosphere 60 (2005) 740-752
37. Craft S.E., Donnelly K.C., Neamtiu I., McCarty K.M., Bruce E., Surkova I., Kim D., Uhnakova I., Gyorffy E., Tesarova E., and Anderson B. Prioritizing environmental issues around the world: opinions from an international central and eastern European environmental health conference. Environ. Health Perspect. 114 12 (2006) 1813-1817
38. Suk W.A., Ruchirawat K.M., Balakrishnan K., Berger M., Carpenter D., Damstra T., De Garbino J.P., Koh D., Landrigan P.J., Makalinao I., Sly P.D., Xu Y., and Zheng B.S. Environmental threats to children's health in Southeast Asia and the Western Pacific. Environ. Health Perspect. 111 10 (2003) 1340-1347
39. Kapil A. The challenge of antibiotic resistance: need to contemplate. Ind. J. Med. Res. 12 (2005) 83-91
40. Ijsselmuiden C. Better to die at 50 from cancer than at 1 from malnutrition?. Bull. World Health Org. 78 9 (2000) 1157-1158
41. Vieno N.M., Harkki H., Tuhkanen T., and Kronberg L. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 41 (2007) 5077-5084
42. Jones O.A.H., Voulvoulis N., and Lester J.N. Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit. Rev. Toxicol. 34 4 (2004) 335-350
43. Smith K.R. Environmental health - for the rich or for all?. Bull. World Health Org. 78 9 (2000) 1156-1157
44. Woodward A. Hard choices. Bull. World Health Org. 78 9 (2000) 1156-1157